Baidu
map

2021年9月6日简报:全国新冠疫苗接种剂次超21亿,新冠肺炎灭活疫苗第三针加强补种方案已提交审批,国产mRNA疫苗仍然在路上

2021-09-06 MedSci整理 MedSci整理

截至北京时间2021年9月6日7时01分,Worldometers世界实时统计数据显示,全球累计确诊新冠肺炎(COVID-19)病例超过22150万例,新增415,884例,达到221,507,899

截至北京时间2021年9月6日7时01分,Worldometers世界实时统计数据显示,全球累计确诊新冠肺炎COVID-19)病例超过22150万例,新增415,884例,达到221,507,899例。累计死亡病例458.1万例,达到4,581,062例。新增死亡为6,391例。康复为197,997,466例,重症和危重症病人达到105,507例;全球新冠确诊病例超过100万例的国家达35个,106个国家病例超10万例。昨日报道:2021年9月5日简报:全球新冠感染超2.2亿人,以色列本轮疫情已超过上一轮;菲律宾连续第2天单日新增2万例;美国儿童确诊病例呈指数级增长

全国新冠疫苗接种超21亿剂次

截至2021年9月4日,31个省(自治区、直辖市)和新疆生产建设兵团累计报告接种新冠病毒疫苗210038.7万剂次。

中国疾控中心免疫规划首席专家王华庆提示,新冠病毒疫苗完成全程接种才能产生更好的免疫效果、保护效果。他建议,还没有完成全程免疫的受种者,一定要按照程序,及时完成接种。

专家建议,在接种疫苗的同时,公众仍然需要做好个人防护,要继续坚持戴口罩、勤洗手、少聚集等良好的卫生习惯。

国药第三针加强补种方案提交审批

国药集团中国生物技术股份有限公司已向有关部门提交新冠肺炎灭活疫苗第三针加强补种方案,正等待方案审批通过。

国药集团中国生物纪委书记陈坤表示,现有实验数据表明,该公司的新冠肺炎灭活疫苗对现有主要新冠病毒变异株依旧有效。

据悉,国药集团中国生物相关实验还表明,在完成该公司灭活疫苗两针剂免疫程序6个月后,开展加强接种,受试者体内抗体水平最高可提升5-10倍,可大幅度提升免疫效果。

该方案建议,针对老年人、窗口性服务业从业者等特殊群体,在完成两剂接种免疫程序后6个月至1年内,可再接种一剂加强针。

香港累计新冠疫苗接种超784万剂次

9月5日,香港特区政府公布,截至5日20时的过去24小时,香港共有约43200人接种了新冠疫苗。

自疫苗接种计划开展以来,香港新冠疫苗接种量累计超过784万剂次,超过424万人已接种首剂新冠疫苗。

专家:美国需与中国合作应对新冠疫情

美国经济学家、国际医学期刊《柳叶刀》杂志新冠委员会主席杰弗里·萨克斯日前在接受马来西亚媒体采访时说,美国需要与中国合作,以共同应对新冠疫情。

马来西亚《星报》5日刊登了该报前首席执行官黄振威对萨克斯的邮件采访。萨克斯在采访中说,全球没有对新冠疫情作出恰当应对,其中一个原因就是美国未能与中国合作找到一个全球性解决方案。

“这是悲剧性的,因为中国在抗击疫情方面做得非常出色,世界本可以也应该从中国的应对方案中学到更多。”萨克斯说:“美国应该学会与中国合作,而不是试图将其自身意志强加于中国。”

国产mRNA新冠疫苗,仍然在路上,艰难前行

自新冠疫情暴发以来,mRNA技术便作为“救世明星”走进大众视野——一声枪响,各国mRNA疫苗“马拉松”便拉开帷幕。作为逐梦国产疫苗“决赛圈”的选手之一,沃森生物此举备受瞩目。然而,沃森中报上却并无相关消息,甚至,从2020年到2021年中报,其玉溪沃森疫苗产业园三期工程投资,进度条始终“卡壳” 在99.56%。

2020年年初,国内意欲进军mRNA新冠疫苗企业多达十余家。到今天,至少6家本土企业已经“弃赛”——其中,既有原本声称3个月完成投产的华大基因子公司华大吉诺因,也有不久前因“一女四嫁”而登上热点的嘉晨四海。只有四家企业进入比赛中段,获得国家下发的临床试验批件。即艾博生物(沃森生物合作方)、复星医药、斯微生物以及丽凡达生物。后两者在近几个月的耐力拉扯中,较显乏力。

在斯微生物今年1月4日获批临床、3月25日正式启动一期临床后,西藏药业却在8月28日宣布停止战略合作,转为股权投资。

无独有偶,原本在今年三月就启动临床试验的丽凡达生物,也面临投资人后撤的局面。

根据业内人士披露的沃森生物8月份会议纪要,当时,公司对疫苗投产获批前景表示乐观:

会议提到,根据目前数据反馈,疫苗对各毒株的保护效率有92.4%,高于世界其他已经上市的mRNA疫苗,进展比较顺利。国内第一针mRNA新冠疫苗7月底在柳州开打,预计8月底有数据反馈。

不过,到8月31日,沃森生物并未披露国内临床试验数据,并开始在墨西哥、印尼两国开展疫苗III期临床试验。

会议还提到,沃森生物预期其mRNA新冠疫苗将在10月20日进行投产、30日举行海外官方发布会;为配合官方宣传,国内发布会可能在11月开始。

美国此轮疫情,已近顶点

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (8)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=2078868, encodeId=e22920e886865, content=<a href='/topic/show?id=f48865242bb' target=_blank style='color:#2F92EE;'>#活疫苗#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=69, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=65242, encryptionId=f48865242bb, topicName=活疫苗)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e4aa106, createdName=crystal0562, createdTime=Tue Oct 12 22:13:51 CST 2021, time=2021-10-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1947418, encodeId=4574194e41840, content=<a href='/topic/show?id=88d81556543' target=_blank style='color:#2F92EE;'>#RNA疫苗#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=69, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=15565, encryptionId=88d81556543, topicName=RNA疫苗)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ce072500140, createdName=12498b3em08(暂无昵称), createdTime=Sat Sep 25 02:13:51 CST 2021, time=2021-09-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1258089, encodeId=f9f71258089b8, content=<a href='/topic/show?id=f538e0501e9' target=_blank style='color:#2F92EE;'>#疫苗接种#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=100, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=70501, encryptionId=f538e0501e9, topicName=疫苗接种)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5c0050, createdName=lishiwen, createdTime=Tue Sep 07 22:13:51 CST 2021, time=2021-09-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1015053, encodeId=186e10150539a, content=学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=95, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201123/ec6818f0b3a34c76b9db53c38ef58f13/763f5e8fbc8a4bc1a486cfe5b4e09829.jpg, createdBy=43595437601, createdName=Yuxintong66 , createdTime=Mon Sep 06 13:54:20 CST 2021, time=2021-09-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1014962, encodeId=5918101496249, content=可以期待一下, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=821f2227826, createdName=DR.Fu SIR, createdTime=Mon Sep 06 09:13:55 CST 2021, time=2021-09-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1015039, encodeId=746c101503986, content=我们还要加强疫苗接种工作, beContent=null, objectType=article, channel=null, level=null, likeNumber=86, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a4443282149, createdName=12d769e1m77暂无昵称, createdTime=Mon Sep 06 13:25:10 CST 2021, time=2021-09-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1029933, encodeId=d7621029933ee, content=新冠肺炎,疫情何时才能消失, beContent=null, objectType=article, channel=null, level=null, likeNumber=83, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=公卫新人, createdTime=Mon Sep 06 10:13:51 CST 2021, time=2021-09-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1014927, encodeId=1e58101492ebd, content=不错不错, beContent=null, objectType=article, channel=null, level=null, likeNumber=99, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210830/6e21298998ee404a98a9f9f18d4fd636/6dfb1526eb8d47dba5515dd0709385e8.jpg, createdBy=dc685586392, createdName=onebutton, createdTime=Mon Sep 06 08:15:24 CST 2021, time=2021-09-06, status=1, ipAttribution=)]
  2. [GetPortalCommentsPageByObjectIdResponse(id=2078868, encodeId=e22920e886865, content=<a href='/topic/show?id=f48865242bb' target=_blank style='color:#2F92EE;'>#活疫苗#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=69, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=65242, encryptionId=f48865242bb, topicName=活疫苗)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e4aa106, createdName=crystal0562, createdTime=Tue Oct 12 22:13:51 CST 2021, time=2021-10-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1947418, encodeId=4574194e41840, content=<a href='/topic/show?id=88d81556543' target=_blank style='color:#2F92EE;'>#RNA疫苗#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=69, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=15565, encryptionId=88d81556543, topicName=RNA疫苗)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ce072500140, createdName=12498b3em08(暂无昵称), createdTime=Sat Sep 25 02:13:51 CST 2021, time=2021-09-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1258089, encodeId=f9f71258089b8, content=<a href='/topic/show?id=f538e0501e9' target=_blank style='color:#2F92EE;'>#疫苗接种#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=100, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=70501, encryptionId=f538e0501e9, topicName=疫苗接种)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5c0050, createdName=lishiwen, createdTime=Tue Sep 07 22:13:51 CST 2021, time=2021-09-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1015053, encodeId=186e10150539a, content=学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=95, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201123/ec6818f0b3a34c76b9db53c38ef58f13/763f5e8fbc8a4bc1a486cfe5b4e09829.jpg, createdBy=43595437601, createdName=Yuxintong66 , createdTime=Mon Sep 06 13:54:20 CST 2021, time=2021-09-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1014962, encodeId=5918101496249, content=可以期待一下, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=821f2227826, createdName=DR.Fu SIR, createdTime=Mon Sep 06 09:13:55 CST 2021, time=2021-09-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1015039, encodeId=746c101503986, content=我们还要加强疫苗接种工作, beContent=null, objectType=article, channel=null, level=null, likeNumber=86, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a4443282149, createdName=12d769e1m77暂无昵称, createdTime=Mon Sep 06 13:25:10 CST 2021, time=2021-09-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1029933, encodeId=d7621029933ee, content=新冠肺炎,疫情何时才能消失, beContent=null, objectType=article, channel=null, level=null, likeNumber=83, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=公卫新人, createdTime=Mon Sep 06 10:13:51 CST 2021, time=2021-09-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1014927, encodeId=1e58101492ebd, content=不错不错, beContent=null, objectType=article, channel=null, level=null, likeNumber=99, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210830/6e21298998ee404a98a9f9f18d4fd636/6dfb1526eb8d47dba5515dd0709385e8.jpg, createdBy=dc685586392, createdName=onebutton, createdTime=Mon Sep 06 08:15:24 CST 2021, time=2021-09-06, status=1, ipAttribution=)]
  3. [GetPortalCommentsPageByObjectIdResponse(id=2078868, encodeId=e22920e886865, content=<a href='/topic/show?id=f48865242bb' target=_blank style='color:#2F92EE;'>#活疫苗#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=69, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=65242, encryptionId=f48865242bb, topicName=活疫苗)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e4aa106, createdName=crystal0562, createdTime=Tue Oct 12 22:13:51 CST 2021, time=2021-10-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1947418, encodeId=4574194e41840, content=<a href='/topic/show?id=88d81556543' target=_blank style='color:#2F92EE;'>#RNA疫苗#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=69, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=15565, encryptionId=88d81556543, topicName=RNA疫苗)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ce072500140, createdName=12498b3em08(暂无昵称), createdTime=Sat Sep 25 02:13:51 CST 2021, time=2021-09-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1258089, encodeId=f9f71258089b8, content=<a href='/topic/show?id=f538e0501e9' target=_blank style='color:#2F92EE;'>#疫苗接种#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=100, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=70501, encryptionId=f538e0501e9, topicName=疫苗接种)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5c0050, createdName=lishiwen, createdTime=Tue Sep 07 22:13:51 CST 2021, time=2021-09-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1015053, encodeId=186e10150539a, content=学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=95, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201123/ec6818f0b3a34c76b9db53c38ef58f13/763f5e8fbc8a4bc1a486cfe5b4e09829.jpg, createdBy=43595437601, createdName=Yuxintong66 , createdTime=Mon Sep 06 13:54:20 CST 2021, time=2021-09-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1014962, encodeId=5918101496249, content=可以期待一下, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=821f2227826, createdName=DR.Fu SIR, createdTime=Mon Sep 06 09:13:55 CST 2021, time=2021-09-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1015039, encodeId=746c101503986, content=我们还要加强疫苗接种工作, beContent=null, objectType=article, channel=null, level=null, likeNumber=86, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a4443282149, createdName=12d769e1m77暂无昵称, createdTime=Mon Sep 06 13:25:10 CST 2021, time=2021-09-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1029933, encodeId=d7621029933ee, content=新冠肺炎,疫情何时才能消失, beContent=null, objectType=article, channel=null, level=null, likeNumber=83, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=公卫新人, createdTime=Mon Sep 06 10:13:51 CST 2021, time=2021-09-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1014927, encodeId=1e58101492ebd, content=不错不错, beContent=null, objectType=article, channel=null, level=null, likeNumber=99, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210830/6e21298998ee404a98a9f9f18d4fd636/6dfb1526eb8d47dba5515dd0709385e8.jpg, createdBy=dc685586392, createdName=onebutton, createdTime=Mon Sep 06 08:15:24 CST 2021, time=2021-09-06, status=1, ipAttribution=)]
  4. [GetPortalCommentsPageByObjectIdResponse(id=2078868, encodeId=e22920e886865, content=<a href='/topic/show?id=f48865242bb' target=_blank style='color:#2F92EE;'>#活疫苗#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=69, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=65242, encryptionId=f48865242bb, topicName=活疫苗)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e4aa106, createdName=crystal0562, createdTime=Tue Oct 12 22:13:51 CST 2021, time=2021-10-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1947418, encodeId=4574194e41840, content=<a href='/topic/show?id=88d81556543' target=_blank style='color:#2F92EE;'>#RNA疫苗#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=69, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=15565, encryptionId=88d81556543, topicName=RNA疫苗)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ce072500140, createdName=12498b3em08(暂无昵称), createdTime=Sat Sep 25 02:13:51 CST 2021, time=2021-09-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1258089, encodeId=f9f71258089b8, content=<a href='/topic/show?id=f538e0501e9' target=_blank style='color:#2F92EE;'>#疫苗接种#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=100, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=70501, encryptionId=f538e0501e9, topicName=疫苗接种)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5c0050, createdName=lishiwen, createdTime=Tue Sep 07 22:13:51 CST 2021, time=2021-09-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1015053, encodeId=186e10150539a, content=学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=95, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201123/ec6818f0b3a34c76b9db53c38ef58f13/763f5e8fbc8a4bc1a486cfe5b4e09829.jpg, createdBy=43595437601, createdName=Yuxintong66 , createdTime=Mon Sep 06 13:54:20 CST 2021, time=2021-09-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1014962, encodeId=5918101496249, content=可以期待一下, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=821f2227826, createdName=DR.Fu SIR, createdTime=Mon Sep 06 09:13:55 CST 2021, time=2021-09-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1015039, encodeId=746c101503986, content=我们还要加强疫苗接种工作, beContent=null, objectType=article, channel=null, level=null, likeNumber=86, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a4443282149, createdName=12d769e1m77暂无昵称, createdTime=Mon Sep 06 13:25:10 CST 2021, time=2021-09-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1029933, encodeId=d7621029933ee, content=新冠肺炎,疫情何时才能消失, beContent=null, objectType=article, channel=null, level=null, likeNumber=83, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=公卫新人, createdTime=Mon Sep 06 10:13:51 CST 2021, time=2021-09-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1014927, encodeId=1e58101492ebd, content=不错不错, beContent=null, objectType=article, channel=null, level=null, likeNumber=99, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210830/6e21298998ee404a98a9f9f18d4fd636/6dfb1526eb8d47dba5515dd0709385e8.jpg, createdBy=dc685586392, createdName=onebutton, createdTime=Mon Sep 06 08:15:24 CST 2021, time=2021-09-06, status=1, ipAttribution=)]
    2021-09-06 Yuxintong66

    学习

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=2078868, encodeId=e22920e886865, content=<a href='/topic/show?id=f48865242bb' target=_blank style='color:#2F92EE;'>#活疫苗#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=69, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=65242, encryptionId=f48865242bb, topicName=活疫苗)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e4aa106, createdName=crystal0562, createdTime=Tue Oct 12 22:13:51 CST 2021, time=2021-10-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1947418, encodeId=4574194e41840, content=<a href='/topic/show?id=88d81556543' target=_blank style='color:#2F92EE;'>#RNA疫苗#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=69, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=15565, encryptionId=88d81556543, topicName=RNA疫苗)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ce072500140, createdName=12498b3em08(暂无昵称), createdTime=Sat Sep 25 02:13:51 CST 2021, time=2021-09-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1258089, encodeId=f9f71258089b8, content=<a href='/topic/show?id=f538e0501e9' target=_blank style='color:#2F92EE;'>#疫苗接种#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=100, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=70501, encryptionId=f538e0501e9, topicName=疫苗接种)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5c0050, createdName=lishiwen, createdTime=Tue Sep 07 22:13:51 CST 2021, time=2021-09-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1015053, encodeId=186e10150539a, content=学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=95, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201123/ec6818f0b3a34c76b9db53c38ef58f13/763f5e8fbc8a4bc1a486cfe5b4e09829.jpg, createdBy=43595437601, createdName=Yuxintong66 , createdTime=Mon Sep 06 13:54:20 CST 2021, time=2021-09-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1014962, encodeId=5918101496249, content=可以期待一下, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=821f2227826, createdName=DR.Fu SIR, createdTime=Mon Sep 06 09:13:55 CST 2021, time=2021-09-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1015039, encodeId=746c101503986, content=我们还要加强疫苗接种工作, beContent=null, objectType=article, channel=null, level=null, likeNumber=86, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a4443282149, createdName=12d769e1m77暂无昵称, createdTime=Mon Sep 06 13:25:10 CST 2021, time=2021-09-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1029933, encodeId=d7621029933ee, content=新冠肺炎,疫情何时才能消失, beContent=null, objectType=article, channel=null, level=null, likeNumber=83, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=公卫新人, createdTime=Mon Sep 06 10:13:51 CST 2021, time=2021-09-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1014927, encodeId=1e58101492ebd, content=不错不错, beContent=null, objectType=article, channel=null, level=null, likeNumber=99, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210830/6e21298998ee404a98a9f9f18d4fd636/6dfb1526eb8d47dba5515dd0709385e8.jpg, createdBy=dc685586392, createdName=onebutton, createdTime=Mon Sep 06 08:15:24 CST 2021, time=2021-09-06, status=1, ipAttribution=)]
    2021-09-06 DR.Fu SIR

    可以期待一下

    0

  6. [GetPortalCommentsPageByObjectIdResponse(id=2078868, encodeId=e22920e886865, content=<a href='/topic/show?id=f48865242bb' target=_blank style='color:#2F92EE;'>#活疫苗#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=69, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=65242, encryptionId=f48865242bb, topicName=活疫苗)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e4aa106, createdName=crystal0562, createdTime=Tue Oct 12 22:13:51 CST 2021, time=2021-10-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1947418, encodeId=4574194e41840, content=<a href='/topic/show?id=88d81556543' target=_blank style='color:#2F92EE;'>#RNA疫苗#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=69, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=15565, encryptionId=88d81556543, topicName=RNA疫苗)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ce072500140, createdName=12498b3em08(暂无昵称), createdTime=Sat Sep 25 02:13:51 CST 2021, time=2021-09-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1258089, encodeId=f9f71258089b8, content=<a href='/topic/show?id=f538e0501e9' target=_blank style='color:#2F92EE;'>#疫苗接种#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=100, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=70501, encryptionId=f538e0501e9, topicName=疫苗接种)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5c0050, createdName=lishiwen, createdTime=Tue Sep 07 22:13:51 CST 2021, time=2021-09-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1015053, encodeId=186e10150539a, content=学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=95, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201123/ec6818f0b3a34c76b9db53c38ef58f13/763f5e8fbc8a4bc1a486cfe5b4e09829.jpg, createdBy=43595437601, createdName=Yuxintong66 , createdTime=Mon Sep 06 13:54:20 CST 2021, time=2021-09-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1014962, encodeId=5918101496249, content=可以期待一下, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=821f2227826, createdName=DR.Fu SIR, createdTime=Mon Sep 06 09:13:55 CST 2021, time=2021-09-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1015039, encodeId=746c101503986, content=我们还要加强疫苗接种工作, beContent=null, objectType=article, channel=null, level=null, likeNumber=86, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a4443282149, createdName=12d769e1m77暂无昵称, createdTime=Mon Sep 06 13:25:10 CST 2021, time=2021-09-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1029933, encodeId=d7621029933ee, content=新冠肺炎,疫情何时才能消失, beContent=null, objectType=article, channel=null, level=null, likeNumber=83, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=公卫新人, createdTime=Mon Sep 06 10:13:51 CST 2021, time=2021-09-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1014927, encodeId=1e58101492ebd, content=不错不错, beContent=null, objectType=article, channel=null, level=null, likeNumber=99, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210830/6e21298998ee404a98a9f9f18d4fd636/6dfb1526eb8d47dba5515dd0709385e8.jpg, createdBy=dc685586392, createdName=onebutton, createdTime=Mon Sep 06 08:15:24 CST 2021, time=2021-09-06, status=1, ipAttribution=)]
    2021-09-06 12d769e1m77暂无昵称

    我们还要加强疫苗接种工作

    0

  7. [GetPortalCommentsPageByObjectIdResponse(id=2078868, encodeId=e22920e886865, content=<a href='/topic/show?id=f48865242bb' target=_blank style='color:#2F92EE;'>#活疫苗#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=69, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=65242, encryptionId=f48865242bb, topicName=活疫苗)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e4aa106, createdName=crystal0562, createdTime=Tue Oct 12 22:13:51 CST 2021, time=2021-10-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1947418, encodeId=4574194e41840, content=<a href='/topic/show?id=88d81556543' target=_blank style='color:#2F92EE;'>#RNA疫苗#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=69, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=15565, encryptionId=88d81556543, topicName=RNA疫苗)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ce072500140, createdName=12498b3em08(暂无昵称), createdTime=Sat Sep 25 02:13:51 CST 2021, time=2021-09-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1258089, encodeId=f9f71258089b8, content=<a href='/topic/show?id=f538e0501e9' target=_blank style='color:#2F92EE;'>#疫苗接种#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=100, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=70501, encryptionId=f538e0501e9, topicName=疫苗接种)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5c0050, createdName=lishiwen, createdTime=Tue Sep 07 22:13:51 CST 2021, time=2021-09-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1015053, encodeId=186e10150539a, content=学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=95, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201123/ec6818f0b3a34c76b9db53c38ef58f13/763f5e8fbc8a4bc1a486cfe5b4e09829.jpg, createdBy=43595437601, createdName=Yuxintong66 , createdTime=Mon Sep 06 13:54:20 CST 2021, time=2021-09-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1014962, encodeId=5918101496249, content=可以期待一下, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=821f2227826, createdName=DR.Fu SIR, createdTime=Mon Sep 06 09:13:55 CST 2021, time=2021-09-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1015039, encodeId=746c101503986, content=我们还要加强疫苗接种工作, beContent=null, objectType=article, channel=null, level=null, likeNumber=86, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a4443282149, createdName=12d769e1m77暂无昵称, createdTime=Mon Sep 06 13:25:10 CST 2021, time=2021-09-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1029933, encodeId=d7621029933ee, content=新冠肺炎,疫情何时才能消失, beContent=null, objectType=article, channel=null, level=null, likeNumber=83, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=公卫新人, createdTime=Mon Sep 06 10:13:51 CST 2021, time=2021-09-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1014927, encodeId=1e58101492ebd, content=不错不错, beContent=null, objectType=article, channel=null, level=null, likeNumber=99, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210830/6e21298998ee404a98a9f9f18d4fd636/6dfb1526eb8d47dba5515dd0709385e8.jpg, createdBy=dc685586392, createdName=onebutton, createdTime=Mon Sep 06 08:15:24 CST 2021, time=2021-09-06, status=1, ipAttribution=)]
    2021-09-06 公卫新人

    新冠肺炎,疫情何时才能消失

    0

  8. [GetPortalCommentsPageByObjectIdResponse(id=2078868, encodeId=e22920e886865, content=<a href='/topic/show?id=f48865242bb' target=_blank style='color:#2F92EE;'>#活疫苗#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=69, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=65242, encryptionId=f48865242bb, topicName=活疫苗)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e4aa106, createdName=crystal0562, createdTime=Tue Oct 12 22:13:51 CST 2021, time=2021-10-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1947418, encodeId=4574194e41840, content=<a href='/topic/show?id=88d81556543' target=_blank style='color:#2F92EE;'>#RNA疫苗#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=69, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=15565, encryptionId=88d81556543, topicName=RNA疫苗)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ce072500140, createdName=12498b3em08(暂无昵称), createdTime=Sat Sep 25 02:13:51 CST 2021, time=2021-09-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1258089, encodeId=f9f71258089b8, content=<a href='/topic/show?id=f538e0501e9' target=_blank style='color:#2F92EE;'>#疫苗接种#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=100, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=70501, encryptionId=f538e0501e9, topicName=疫苗接种)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5c0050, createdName=lishiwen, createdTime=Tue Sep 07 22:13:51 CST 2021, time=2021-09-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1015053, encodeId=186e10150539a, content=学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=95, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201123/ec6818f0b3a34c76b9db53c38ef58f13/763f5e8fbc8a4bc1a486cfe5b4e09829.jpg, createdBy=43595437601, createdName=Yuxintong66 , createdTime=Mon Sep 06 13:54:20 CST 2021, time=2021-09-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1014962, encodeId=5918101496249, content=可以期待一下, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=821f2227826, createdName=DR.Fu SIR, createdTime=Mon Sep 06 09:13:55 CST 2021, time=2021-09-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1015039, encodeId=746c101503986, content=我们还要加强疫苗接种工作, beContent=null, objectType=article, channel=null, level=null, likeNumber=86, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a4443282149, createdName=12d769e1m77暂无昵称, createdTime=Mon Sep 06 13:25:10 CST 2021, time=2021-09-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1029933, encodeId=d7621029933ee, content=新冠肺炎,疫情何时才能消失, beContent=null, objectType=article, channel=null, level=null, likeNumber=83, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=公卫新人, createdTime=Mon Sep 06 10:13:51 CST 2021, time=2021-09-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1014927, encodeId=1e58101492ebd, content=不错不错, beContent=null, objectType=article, channel=null, level=null, likeNumber=99, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210830/6e21298998ee404a98a9f9f18d4fd636/6dfb1526eb8d47dba5515dd0709385e8.jpg, createdBy=dc685586392, createdName=onebutton, createdTime=Mon Sep 06 08:15:24 CST 2021, time=2021-09-06, status=1, ipAttribution=)]
    2021-09-06 onebutton

    不错不错

    0

相关资讯

NEJM:史上大规模真实世界研究,颠覆对新冠疫苗副作用的认知

新冠病毒(SARS-CoV-2))引起的新冠肺炎(COVID-19)大流行已过去 1 年多,全球范围内正在进行数量空前的大规模疫苗接种工作。

2021年8月31日简报:全国多个省市疫苗接种率超过80%;疫苗高接种率国家以色列和新加坡均遭疫情反复;美国反口罩运动领导者死于新冠

截至北京时间2021年8月31日7时01分,Worldometers世界实时统计数据显示,全球累计确诊新冠肺炎(COVID-19)病例超过21777万例,新增468,452例,达到217,778,26

2021年9月3日简报:中国2款升级版灭活苗问世;新冠病毒Mu变种已蔓延至40余国;国产mRNA新冠疫苗预计今年年底问世;超八成美国人有新冠抗体

截至北京时间2021年9月3日7时01分,Worldometers世界实时统计数据显示,全球累计确诊新冠肺炎(COVID-19)病例超过21921万例,新增640,192例,达到219,882,194

2021年9月4日简报:中国向全球提供了9.9亿剂次新冠疫苗;美国三个星期内儿童确诊超50万例;美国首例新冠死亡病例提早至2020年1月9日

截至北京时间2021年9月4日7时01分,Worldometers世界实时统计数据显示,全球累计确诊新冠肺炎(COVID-19)病例超过22058万例,新增656,274例,达到220,588,495

2021年9月1日简报:上海今日启动12-14岁人群新冠疫苗预约接种;南非出现新冠病毒C.1.2变异毒株;以色列研究显示新冠疫苗加强针效果显著 感染风险降低11.4倍

截至北京时间2021年9月1日7时01分,Worldometers世界实时统计数据显示,全球累计确诊新冠肺炎(COVID-19)病例超过21844万例,新增550,331例,达到218,447,397

JNCI:癌症患者接种新冠疫苗 BNT162b2的免疫原性和安全性

在积极治疗的癌症患者可接种 BNT162b2 疫苗,安全性好且有效

Baidu
map
Baidu
map
Baidu
map